Development of a Novel Inhibitory Chimeric Anti-HER2 Monoclonal Antibody

Document Type: Original Article

Authors

1 Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran

2 Monoclonal Antibody Research Center, Avicenna Research Institute, ACECR, Tehran, Iran

3 Department of Immunology, School of Public Health, Tehran University of Medical Sciences,